| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $414.7M | +4.8% | +14.4% |
| Cost of Revenue | $83.6M | +8.6% | +25.5% |
| Gross Profit | $331.1M | +3.9% | +11.9% |
| R&D Expense | $82.8M | +3.1% | -2.3% |
| SG&A Expense | $79.5M | +3.4% | +11.8% |
| Operating Income | -$18.1M | +12.8% | +16.7% |
| Pre-tax Income | -$2.1M | +26.6% | -106.2% |
| Income Tax | $522K | +250.3% | +1060.0% |
| Net Income | -$2.6M | +12.6% | -107.7% |
| EPS (Basic) | -$0.03 | +0.0% | -109.1% |
| EPS (Diluted) | -$0.03 | +0.0% | +50.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.09B | -0.5% | -30.1% |
| Accounts Receivable | $41.2M | +28.2% | +42.4% |
| Current Assets | $7.33B | -0.1% | +7.1% |
| Total Assets | $10.13B | -0.2% | +4.7% |
| Current Liabilities | $4.43B | +1.2% | +7.5% |
| Long-term Debt | $1.83B |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $202.2M | +108.7% | — |
| Capital Expenditures | $2.8M | +114.9% | — |
| Investing Cash Flow | $27.9M | +125.6% | — |
| Financing Cash Flow | -$111.9M | — | — |
| Free Cash Flow | $199.4M | +108.7% | — |
| +9.2% |
| Total Liabilities | $6.32B | +0.8% | +7.8% |
| Stockholders' Equity | $3.81B | -2.0% | -0.1% |